CD8A and melanoma: This is consistent with recent reports highlighting the ability of DC2 to robustly produce type 1 stimulating cytokine IL-12 and sufficiently prime CD8+ T cell responses during a respiratory viral challenge in the lung, as well as polarize antitumor Th1 cells in a s.c. model of murine melanoma (15, 48, 49).